secwatch.observer — SEC 8-K summary
======================================

Issuer:     Coya Therapeutics, Inc. (COYA)
CIK:        0001835022
Form:       8-K
Filed at:   2026-01-30T23:59:59+00:00
Accession:  0001193125-26-030531
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 3.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Coya Therapeutics raises $11.1M via private placement with Dr. Reddy's and Greenlight Capital
--------------------------------------------------------------------------------

- Gross proceeds of ~$11.1M from sale of 2,522,727 shares at $4.40 each; no broker/agent.
- Dr. Reddy's Labs invests $10M, Greenlight Capital $1.1M; expected close Jan 30, 2026.
- Proceeds to accelerate tech transfer and scale-up manufacturing for low dose IL-2 to support COYA 302.
- Reiterates cash runway into H2 2027 and past projected ALSTARS trial topline.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835022/000119312526030531/0001193125-26-030531-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835022/000119312526030531/d88735d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-030531

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer